Atlas Trials

Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta

Clinical trial NCT00117533 · UNKNOWN

Trial details

NCT number
NCT00117533
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis BChronic Hepatitis D
Start date
2005-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.